tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says
The FlyVaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says
2d ago
AZN
BMY
GSK Advances Share Buyback Program with Latest Repurchase
PremiumCompany Announcements
GSK Advances Share Buyback Program with Latest Repurchase
2d ago
GSK Enhances Shareholder Value with Strategic Share Buyback
PremiumCompany Announcements
GSK Enhances Shareholder Value with Strategic Share Buyback
3d ago
Perrigo appoints Matt Winterman as Product Supply, Operation Strategy Officer
PremiumThe Fly
Perrigo appoints Matt Winterman as Product Supply, Operation Strategy Officer
4d ago
AZN
GSK
GSK Enhances Shareholder Value with Latest Share Buyback
PremiumCompany Announcements
GSK Enhances Shareholder Value with Latest Share Buyback
4d ago
GSK Initiates Second Tranche of £2 Billion Share Buyback Program
PremiumCompany AnnouncementsGSK Initiates Second Tranche of £2 Billion Share Buyback Program
4d ago
GSK downgraded to Hold from Buy at Berenberg
Premium
The Fly
GSK downgraded to Hold from Buy at Berenberg
5d ago
GSK
GSK Expands Share Buyback Program with Latest Purchase
Premium
Company Announcements
GSK Expands Share Buyback Program with Latest Purchase
5d ago
GSK Executive Sells 77,000 Shares in Recent Transaction
PremiumCompany Announcements
GSK Executive Sells 77,000 Shares in Recent Transaction
6d ago
GSK Announces Total Voting Rights and Capital Structure
PremiumCompany Announcements
GSK Announces Total Voting Rights and Capital Structure
6d ago
GSK reports linerixibat NDA accepted for review by FDA
PremiumThe Fly
GSK reports linerixibat NDA accepted for review by FDA
6d ago
GSK
Theravance to sell remaining royalty interest in Trelegy to GSK for $225M
PremiumThe Fly
Theravance to sell remaining royalty interest in Trelegy to GSK for $225M
6d ago
GSK
TBPH
GSK Enhances Shareholder Value with Strategic Share Buyback
PremiumCompany AnnouncementsGSK Enhances Shareholder Value with Strategic Share Buyback
6d ago
GSK’s Linerixibat NDA Accepted by FDA for Review
Premium
Company Announcements
GSK’s Linerixibat NDA Accepted by FDA for Review
6d ago
CDC says healthy children may receive COVID vaccination
Premium
The Fly
CDC says healthy children may receive COVID vaccination
9d ago
GSK
PFE
GSK Enhances Share Buyback Program with Latest Share Purchase
PremiumCompany Announcements
GSK Enhances Share Buyback Program with Latest Share Purchase
9d ago
GSK Enhances Shareholder Value with Strategic Share Buyback
PremiumCompany Announcements
GSK Enhances Shareholder Value with Strategic Share Buyback
9d ago
GSK announces new data across oncology pipeline at ASCO, EHA
PremiumThe Fly
GSK announces new data across oncology pipeline at ASCO, EHA
10d ago
GSK
GSK Expands Share Buyback Program with Latest Acquisition
PremiumCompany Announcements
GSK Expands Share Buyback Program with Latest Acquisition
10d ago
Scynexis resumes patient dosing in Phase 3 MARIO study
PremiumThe FlyScynexis resumes patient dosing in Phase 3 MARIO study
11d ago
GSK
SCYX
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
Premium
The Fly
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
11d ago
GSK
SPRO
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
Premium
The Fly
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
11d ago
GSK
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >